MAM
PUMA, Cara Delevingne release colorful collection for pride month
MUMBAI: Global sports company PUMA is spreading the message of love and unity alongside PUMA ambassador and LGBTQ+ activist Cara Delevingne with the launch of the From PUMA with Love pack to celebrate Pride Month. Made to be worn with pride, the collection features vibrant colors, rainbow designs and bold graphics.
The collection is inspired by Cara’s passion to show love, hope and kindness toward one another while also giving back to the LGBTQ+ community and its members.
“This collection was designed and created with so much love. I was really looking forward to wearing it at this year’s Pride celebrations that I was planning to attend but, given the circumstances, I can’t wait to wear it and celebrate Pride month from my home via Zoom and FaceTime,“ said Cara Delevingne. “Through my foundation, I am looking forward to making donations to LGBTQ+ organisations around the world who are making such a difference every single day. The LGBTQ+ community deserves to be celebrated and I’m so grateful PUMA partnered with me to create such a prideful collection.”
The "From PUMA with Love" styles include colorful graphic tees, hoodies and Pride waistbag releases June 24 on Puma.com and select PUMA stores.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
